Cargando…
A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering
A “universal” platform that can rapidly generate multiplex vaccine candidates is critically needed to control pandemics. Using the severe acute respiratory syndrome coronavirus 2 as a model, we have developed such a platform by CRISPR engineering of bacteriophage T4. A pipeline of vaccine candidates...
Autores principales: | Zhu, Jingen, Ananthaswamy, Neeti, Jain, Swati, Batra, Himanshu, Tang, Wei-Chun, Lewry, Douglass A., Richards, Michael L., David, Sunil A., Kilgore, Paul B., Sha, Jian, Drelich, Aleksandra, Tseng, Chien-Te K., Chopra, Ashok K., Rao, Venigalla B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442874/ https://www.ncbi.nlm.nih.gov/pubmed/34516878 http://dx.doi.org/10.1126/sciadv.abh1547 |
Ejemplares similares
-
A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine
por: Zhu, Jingen, et al.
Publicado: (2022) -
Design of bacteriophage T4-based artificial viral vectors for human genome remodeling
por: Zhu, Jingen, et al.
Publicado: (2023) -
Multiplexed selectivity screening of anti-GPCR antibodies
por: Dahl, Leo, et al.
Publicado: (2023) -
Structure and host specificity of Staphylococcus epidermidis bacteriophage Andhra
por: Hawkins, N’Toia C., et al.
Publicado: (2022) -
Sequential apoptotic and multiplexed proteomic evaluation of single cancer cells
por: Lecky, Emmalyn, et al.
Publicado: (2023)